ArticleInsights into imaging2026
Percentage signal recovery plus relative cerebral blood volume: a practical dual-parameter strategy for differentiating post-stereotactic radiosurgery tumour progression from radiation necrosis in brain metastases.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesStereotactic radiosurgery (SRS) is widely used for brain metastases, but differentiating tumour progression from radiation necrosis on conventional MRI remains difficult. Percentage signal recovery (PSR), derived from dynamic susceptibility contrast (DSC) perfusion MRI, reflects signal recovery post-contrast and offers insights into capillary permeability. This study aimed to evaluate PSR and relative cerebral blood volume (rCBV) and assess their combined diagnostic value in post-SRS brain metastases. MATERIALS AND
methodsPatients with enlarging post-SRS brain metastases and diagnostic uncertainty were retrospectively included. PSR and rCBV were extracted from DSC-MRI and normalised to contralateral white matter. The dataset was split into training and validation cohorts using stratified sampling. Logistic regression with 5-fold cross-validation and bootstrap validation was used. Diagnostic performance was assessed by ROC analysis.
resultsSixty-one patients (62 lesions; 26 progression, 36 necrosis) were included. Inter-rater reliability was excellent (ICC > 0.90). Progression showed higher rCBV (2.84 vs. 0.76) and lower PSR (95% vs. 176%) (both p < 0.001). Both were significant in univariate analysis; PSR remained independently predictive (p = 0.04) in multivariate analysis. PSR outperformed rCBV and the combined model in ROC analysis (validation AUCs: 0.960, 0.898, and 0.945, respectively), while the combined PSR and rCBV model maintained excellent sensitivity, specificity, and overall accuracy. Bootstrap-derived thresholds were 108% (PSR) and 1.96 (rCBV). A nomogram was developed for individualised risk estimation.
conclusionsPSR and rCBV provide complementary diagnostic information for post-SRS lesion assessment. PSR may offer additional value without requiring extra image acquisition, and integration of both parameters could enhance diagnostic confidence. Routine inclusion of PSR and rCBV in post-SRS imaging protocols could be recommended. CRITICAL RELEVANCE STATEMENT: This study demonstrates that combining DSC MRI-derived rCBV and PSR improves accuracy and efficiency in distinguishing tumour recurrence from radiation necrosis, offering a practical dual-parameter approach to enhance diagnosis and guide timely clinical decision-making in neurooncology. KEY POINTS: DSC MRI-derived rCBV and PSR may aid in improving diagnostic accuracy and reducing time-to-diagnosis in post-SRS brain metastases. PSR can be derived from the same DSC acquisition without additional scanning or correction and represents a practical parameter for post-SRS lesion assessment. Combining rCBV and PSR may improve diagnostic confidence, especially in equivocal cases, supporting routine use of this dual-parameter model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.